1 National Academy of Clinical Biochemistry: Laboratory medicine practice guidelines, "laboratory support for the diagnosis and monitoring of thyroid disease. . Section 3.C. Thyrotropin/ thyroid stimulating hormone(TSH) measurement." 13 : 33-44, 2003
2 Moruzzi P, "Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy" 81 : 443-447, 1994
3 Carrel T, "Thyronin treatment in adult and pediatric heart surgery clinical experience and review of the literature" 4 : 577-582, 2002
4 Carr AN, "Thyroid hormone regulation of calcium cycling proteins" 12 : 453-457, 2002
5 Ascheim DD, "Thyroid hormone metabolism in patients with congestive heart failure:the low triiodothyronine state" 12 : 511-515, 2002
6 Klein I, "Thyroid hormone and the cardiovascular system" 344 : 501-509, 2001
7 Danzi S, "Thyroid hormone and the cardiovascular system" 29 : 139-149, 2004
8 Klemperer JD, "Thyroid hormone and cardiac surgery" 12 : 517-521, 2002
9 Tunbridge WM, "The spectrum of thyroid disease in a community:the Whickham survey" 7 : 481-493, 1977
10 Kventy J, "The significance of clinical euthyroidism on reference range for thyroid hormones" 14 : 315-320, 2003
1 National Academy of Clinical Biochemistry: Laboratory medicine practice guidelines, "laboratory support for the diagnosis and monitoring of thyroid disease. . Section 3.C. Thyrotropin/ thyroid stimulating hormone(TSH) measurement." 13 : 33-44, 2003
2 Moruzzi P, "Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy" 81 : 443-447, 1994
3 Carrel T, "Thyronin treatment in adult and pediatric heart surgery clinical experience and review of the literature" 4 : 577-582, 2002
4 Carr AN, "Thyroid hormone regulation of calcium cycling proteins" 12 : 453-457, 2002
5 Ascheim DD, "Thyroid hormone metabolism in patients with congestive heart failure:the low triiodothyronine state" 12 : 511-515, 2002
6 Klein I, "Thyroid hormone and the cardiovascular system" 344 : 501-509, 2001
7 Danzi S, "Thyroid hormone and the cardiovascular system" 29 : 139-149, 2004
8 Klemperer JD, "Thyroid hormone and cardiac surgery" 12 : 517-521, 2002
9 Tunbridge WM, "The spectrum of thyroid disease in a community:the Whickham survey" 7 : 481-493, 1977
10 Kventy J, "The significance of clinical euthyroidism on reference range for thyroid hormones" 14 : 315-320, 2003
11 French JM, "The incidence of thyroid disorders inthe community a twenty year follow up of the Whickham survey" 43 : 55-68, 1995
12 Canaris GJ, "The Colorado thyroid disease prevalence study" 160 : 526-534, 2000
13 Burmeister LA, "Subclinical thyrotoxicosis and the heart" 12 : 495-499, 2002
14 Col NF, "Subclinical thyroid disease.Clinical applications" 291 : 239-243, 2004
15 Hak AE, "Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction inelderly women:The Rotterdam Study" 132 : 270-278, 2000
16 Biondi B, "Subclinical hypothyroidism and cardiac function" 12 : 505-510, 2002
17 Sawin C, "Subclinical hyperthyroidism and atrial fibrillation" 12 : 501-503, 2002
18 Hollowell JG, "Serum TSH, T4 and thyroid antibodies in the United States population(1988 to 1994) National Health and Nutrition Examination Survey(NHANES III)." 87 : 489-499, 2002
19 Surks MI, "Scientific review and guidelines for diagnosis and management" 291 : 228- 238, 2004
20 Parle JV, "Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result:a 10-year cohort study" 358 : 861-865, 2001
21 Morkin E,, "Pilot studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analog, in the treatment of congestive heart failure" 97 : 218- 225, 2002
22 Davies PJ, "Nongenomic action of thyroid hormone on the heart" 12 : 459-466, 2002
23 Franklyn J, "Mortality after treatment of hyperthyroidism with radioactive iodine" 338 : 712-718, 1998
24 Thiermann C, "Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure" 142 : 1049-1051, 2004
25 Napoli R, "Impact of hyperthyroidism and its correction on vascular reactivity in humans" 104 : 3076-3080, 2001
26 Shimizu T, "Hyperthyroidisn and the management of atrial fibrillation" 12 : 489-493, 2002
27 Osman F, "Hyperthyroidism and cardiovascular morbidity and mortality" 12 : 483-487, 2002
28 Nordyke RA, "Graves' disease.Influence of age on clinical findings" 148 : 626-631, 1988
29 Weetman AP, "Graves' disease" 343 : 1236-1248, 2000
30 Fazio S, "Effects of thyroid hormone on the cardiovascular system" 59 : 31-50, 2004
31 Biondi B, "Effects of thyroid hormone on cardiac function:the relative importance of heart rate,loading conditions,and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism" 87 : 968-974, 2002
32 Biondi B, "Effects of subclinical thyroid dysfunction on the heart" 137 : 904-914, 2002
33 Fatourechi V, "Effects of reducing the upper limit of normal TSH values" 290 : 3195-3196, 2003
34 Harajai KJ, "Effects of amiodarone on thyroid function" 126 : 63-73, 1997
35 Bartalena L, "Diagnosis and management of amiodarone- induced thyrotoxicosis in Europe:results of an international survey among members of the European Thyroid Association" 61 : 494-502, 2004
36 Kurnik D,, "Complex drug-drug-disease interactions between amiodarone, warfarin and the thyroid gland." Medicine 107-113, 2004
37 Eur J Heart Fail, "Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure." 12 : 5 527-12 533, 2002
38 Dillmann WH, "Cellular action of thyroid hormone on the heart" 12 : 447-452, 2002
39 Kahaly GJ, "Cardiovascular hemodynamics and exercise tolerance in thyroid disease" 12 : 473-481, 2002
40 Friberg L, "Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction" 111 : 699-703, 2001
41 Erdogan MF, "A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis" 13 : 205-209, 2003
국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
KCI
